Fact sheet: Invesco Global Health Care

Fund information

Fund name
Invesco Global Health Care A USD
Fund company manager
Invesco Global Asset Mgmt Ltd
Fund type
SIB
Fund manager(s)
Henry Wu
since 30/04/2017
Derek Taner
since 01/01/2006
Fund objective
The Fund aims to achieve long term capital growth by investing in shares of healthcare companies throughout the world. For the full objectives and investment policy please consult the current prospectus.
Benchmark
MSCI World Health Care
Investment style
Growth
Investment method
Shares

Performance snapshot

Sector
Fund
Sector
Fund
Sector
Fund

Quick stats

1 Year return

14.23 %

1 Year rank in sector

20/30

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 462.5 m

FE Risk score

169

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    77.6%
  • Money Market
    5.8%
  • Switzerland
    5.6%
  • Germany
    2.5%
  • Japan
    2.1%
  • Biotechnology/Medical
    35.3%
  • Pharmaceuticals
    28%
  • Health Care
    16.7%
  • Healthcare & Medical Products
    13.5%
  • Money Market
    5.8%
  • US Equities
    77.6%
  • Money Market
    5.8%
  • Swiss Equities
    5.6%
  • German Equities
    2.5%
  • Japanese Equities
    2.1%

Performance vs. Sector

Sector
Fund
Sector
Fund
Sector
Fund

Cumulative performance

1m6m1y3y5y
Fund3.51 %2.14 %14.23 %1.03 %57.04 %
Sector3.73 %2.7 %14.98 %11.64 %96.5 %
Rank within sector18 / 3120 / 3120 / 3021 / 2722 / 23
Quartile th3 rd3 rd3 rd4 th4 th

Calendar performance

YTD-20182017201620152014
Fund2.46 %14.37 %-13.51 %1.02 %19.31 %
Sector3.38 %14.94 %-9.92 %7.24 %28.08 %
Rank within sector21 / 3119 / 3018 / 3026 / 2722 / 24
Quartile th3 rd3 rd3 rd4 th4 th

Risk statistics

Alpha-3.41
Beta1.03
Sharpe-0.01
Volatility16.46
Tracking error5.06
Information ratio-0.68
R-Squared0.91

Price movement

52 week high134.03
52 week low113.28
Current bid price0
Current offer price0
Current mid price131.98

Holdings by region

  • 77.6% USA
  • 5.8% Money Market
  • 5.6% Switzerland
  • 2.5% Germany
  • 2.1% Japan
  • 2% Denmark
  • 1.2% UK
  • 1.1% Brazil
  • 1.1% Netherlands
  • 1% Others

Holdings by sector

  • 35.3% Biotechnology/Medical
  • 28% Pharmaceuticals
  • 16.7% Health Care
  • 13.5% Healthcare & Medical Products
  • 5.8% Money Market
  • 0.7% Food & Drug Retailers

Holdings by asset type

  • 77.6% US Equities
  • 5.8% Money Market
  • 5.6% Swiss Equities
  • 2.5% German Equities
  • 2.1% Japanese Equities
  • 2% Danish Equities
  • 1.2% UK Equities
  • 1.1% Brazilian Equities
  • 1.1% Dutch Equities
  • 1% International Equities

Individual holdings

  • 4.8% CELGENE CORP
  • 4.2% THERMO FISHER SCIENTIFIC INC
  • 4% NOVARTIS AG
  • 4% UNITEDHEALTH GROUP INC
  • 3.4% BRISTOL MYERS SQUIBB SA
  • 3.2% ZIMMER BIOMET HLDGS INC
  • 3.1% LILLY (ELI) & CO
  • 2.7% BIOMARIN PHARMACEUTICAL INC COMMON STOCK USD.001
  • 2.6% ALEXION PHARMACEUTICALS INC
  • 2.6% SHIRE PLC